Smaller Japanese Drug Makers See No Benefits From New Drug Policy
This article was originally published in PharmAsia News
Executive Summary
Japanese drug makers that are not among the major pharmaceutical players say they would not benefit from the government's plan to promote generics at the same time it maintains branded drug prices at constant levels